Instrument adds assessment power

Article

An age-adjusted retinal nerve fiber layer thickness normative database for a proprietary ocular coherence tomography device gives clinicians a tool for assessing glaucoma risk from a patient's first visit.

FDA clearance of the normative database was announced at Vision Expo West in Las Vegas.

The normative database, combined with the OCT instrument's new posterior pole asymmetry analysis and existing fovea-to-disc (FoDi) alignment software and active eye-tracking capability (via proprietary TruTrack technology), is designed to add to the power and usefulness of the instrument for glaucoma risk assessment and progression management.

"This technology is an important addition to our glaucoma assessment toolbox," Dr. Asrani said. "The combination of [the OCT device's] precision with the new normative database and the asymmetry analysis adds to our ability to detect glaucomatous changes as well as changes over time."

The normative database and asymmetry analysis are part of the instrument's Version 5.3 software. The proprietary OCT's platform features fovea-to-disc alignment technology (FoDi) that is designed to improve the accuracy and reproducibility of RNFL measurements by automatically tracking and anatomically aligning circle scans. The alignment technology helps overcome measurement errors due to patients' changing their head or eye position during scanning.

The alignment technology improves the data integrity of the normative database, according to Heidelberg Engineering. Using the instrument's proprietary eye-tracking technology, all scans in the database are aligned along the fovea-to-disc axis, ensuring point-to-point thickness comparisons.

"It's quite a robust normative database," Dr. Asrani said. "In my experience, if there is an abnormality in a patient's eye indicative of possible early glaucomatous changes, the database frequently identifies it."

Along with the normative database, the device's Version 5.3 software release also includes a posterior pole asymmetry analysis capability.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.